CGAS and cancer: Altering radiation dosage protocols has been demonstrated to enhance type I interferon production, dendritic cell activation, and endogenous cytotoxic T lymphocyte responses against tumors by preventing TREX1 induction.138 Cancer cells have been found to downregulate cGAS or STING expression to effectively evade immune surveillance, inhibiting intracellular pathway activation.